Science Abstracts
Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues
September 2008
September 2008
Authors : Renato Caviglia , Ivo Boškoski , Michele Cicala
Affliation : Department of Digestive Diseases, Campus Bio-Medico University, Via Alvaro Del Portillo, 200, 00100 Roma, Italy ; r.caviglia@unicampus.it
DOI : 10.1517/14740338.7.5.617
Published in : Expert Opin. Drug Saf. Volume 7 Issue 5 2008 pages 617 632
Subject: Drug Safety Evaluation
Keywords: Crohn's disease , infections , inflammatory bowel disease , infliximab , malignancy , safety , ulcerative colitis
Abstract
Crohn's disease and ulcerative colitis represent...
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA seeks panel advice on aptness of adult Remicade data in peds for colitis
- ODAC backs ApoPharma's iron chelator, but lacks harmony on prostate cancer trials
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
- Coronado gets $25.8 million boost to pursue parasite-based autoimmune disease therapy
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
